For the past two years, the Food and Drug Administration (FDA) has been working intensively on improving the safety and quality of generic medical products, which represent nearly 70% of a medical products used by the American population. Following you will find some information on the FDA's initiative and on the measures the Administration has taken in order to increase the safety of generic these products.
1. First and foremost, the FDA has proposed a significant budget increase for the improvement of medical products safety, an increase which can allow them to make all the necessary changes. Their initiative includes using the investments in order to implement new methods for an efficient control of the safety and security of medical products US patients rely on.
2. The first step of this process is represented by an increased oversight of medical products in the supply chain. In order to ensure that these products are in compliance with FDA safety standards, the Administration has increased the number of field exams and inspections as well as its access to inspection data and results issued by other, foreign regulatory authorities.
3. Additionally, the FDA has increased its response to the arising of various issues, by more quickly targeting the company responsible for the problem and by more rapidly identifying companies that have not violated the safety standard. What is more, the FDA has strengthened its collaboration with local and state authorities in order to come up with an efficient response.
4. In order to target areas of greater risk, the FDA has been using the extra budget to invest in updated technology systems, increased analysis of relevant data, better recruitment and enhanced training courses for staff in the statistical and decisional fields, and improvements in the fields of natural sciences and engineering. All of this improvements and upgrades were made with the intention of better targeting medical companies that violate FDA safety standards.
5. Another way of improving safety for the FDA is by establishing a better relationship with patients. More specifically, the FDA will focus on improving risk communication so that patients can understand what they can do and what they should not do in case of safety problems.
6. The FDA has been working on improving the safety of a wide range of these products, including biological products (blood, tissue, and vaccines), medical devices, human drugs (especially generic drugs), veterinary drugs and feeds, and pediatric products. Some measures include the modernizing of the standards for producing and manufacturing these products, increased supervision of the manufacturing process, the development of new screening tests, the improvement of safety reviews for various devices, increased level of sampling, and so on.
In conclusion, the FDA's measures to increase the safety of medical products represent an honorable initiative that is already starting to show results. Hopefully, the Administration will continue on this track for many years to come so that American patients can enjoy safe and secure these products. For more information on the FDA's initiative, contact their official website.